Argent Bio. Share News (RGT)
RGT Share
RGT Share
RGT Share
RGT Share
RGT
RGT Share
RGT Level 2
RGT Live
RGT Broker
RGT Directors
RGT Financial
RGT
RGT Short
RGT
Last checked at -
(Alliance News) - Argent BioPharma Ltd on Tuesday celebrated the approval of its shares to trading in the US, and also announced the appointment of its new chief financial officer.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read more
Asia-focused teaching group, AEC Education, have shown a strong progress in the half year to June 30, boasting a revenue increase of 169% to £8.64m (2009: £3.21m). This result is contributed heavily by the first full six month contribution from Malvern House (£4.12m), the London-based English langua
Read moreLONDON (Dow Jones)--ReGen Therapeutics PLC (RGT.LN), a U.K. developer of healthcare products, said Thursday it has recently ordered a custom made filtration unit for use in the production of its nutraceutical product Colostrinin. MAIN FACTS: -Previously ReGen has hired this equipment, which
Read moreLONDON (Dow Jones)--ReGen Therapeutics PLC(RGT.LN) said Friday it has conditionally placed 3.5 million new ordinary shares at 2 pence per ordinary share to raise GBP70,000 before expenses for general working capital purposes. MAIN FACTS: -The new ordinary shares will represent 4.99% of the e
Read moreLONDON (Dow Jones)--ReGen Therapeutics PLC (RGT.LN), a pharmaceutical company, Wednesday said USV Ltd has been appointed as the exclusive distributor of ReGen's nutritional supplement Colostrinin(TM) in India as announced in April. MAIN FACTS: -For commercial reasons the company had requeste
Read moreLONDON (Dow Jones)--ReGen Therapeutics Plc (RGT.LN) said Monday revenue for the first half of 2010 is estimated to be GBP132,000 compared with total revenues in 2009 of GBP56,055. MAIN FACTS: -This revenue has come from several of the markets where Colostrinin is now on sale and we look to c
Read moreLONDON (Dow Jones)--Biopharmaceutical company ReGen Therapeutics PLC (RGT.LN), said Friday it has conditionally placed 5 million new shares at 2 pence per share to raise GBP100,000, before expenses, for general working capital purposes. MAIN FACTS: -The new ordinary shares will represent 7.5
Read moreLONDON (Dow Jones)--ReGen Therapeutics PLC (RGT.LN), said Thursday that it has appointed Innovation China U.K. (ICUK) to assist in discussions with a major pharmaceutical company in China, which the company hopes will lead to the establishment of ReGen's business in this growing and important health
Read moreDigital media software designer ANT gained ground after German set-top-box maker Kathrein-Werke licensed the ANT Galio Platform to target the Hybrid Broadcast Broadband TV (HbbTV) market. HbbTV, launched in August 2009, combines broadcast TV and broadband TV to provide enhanced digital TV services
Read moreOil group Nautical Petroleum reported 'significant progress' in its asset portfolio in the year to June 30 and said it expects its assets to rise in value once they move into the execution stage. Pre-tax losses for the year totalled £6.63m, compared with £4.52m the previous year. Shares in e-learn
Read morePharmaceutical company ReGen Therapeutics said it will not achieve sustainable profitability until 2010. Up until recently the group said it would reach profitability in the current year. "The credit crunch has had a severe impact on the business of our appointed and potential distributors and t
Read more
Last checked at